Tutorials
Bioventus Inc logo

Bioventus Inc

$ 9.08 +0.66 (+7.84%) 08:08 PM EST
P/E:
67.26
P/B:
1.24
Market Cap:
$ 559.84M
Enterprise V:
$ 900.80M
Volume:
224.16K
Avg Vol (2M):
217.02K
Volume:
224.16K
Market Cap $:
559.84M
PE Ratio:
67.26
Avg Vol (2-Month):
217.02K
Enterprise Value $:
900.80M
PB Ratio:
1.24
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Bioventus Inc
NAICS : 339112 SIC : 3845
4721 Emperor Boulevard, Suite 100, Durham, NC, USA, 27703
Compare
Compare
OFIX SRDX VRAY SENS UFPT NNOX INGN ZIMV SIBN RBOT ABT MDT SYK EW BSX SZSE:300760 DXCM ZBH STE ALGN
Traded in other countries / regions
BVS.USA
Description
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies.
Name Current Vs Industry Vs History
Cash-To-Debt 0.07
Equity-to-Asset 0.38
Debt-to-Equity 0.82
Debt-to-EBITDA 25.09
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.85
Distress
Grey
Safe
Beneish M-Score -2.02
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 68.96
9-Day RSI 64.26
14-Day RSI 59.85
6-1 Month Momentum % -37.32
12-1 Month Momentum % -49.14

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.43
Quick Ratio 1.05
Cash Ratio 0.16
Days Inventory 117.14
Days Sales Outstanding 84.7
Days Payable 34.87

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.3

Financials (Next Earnings Date:2022-11-09 Est.)

BVS's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:BVS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 466.41
EPS (TTM) ($) 0.135
Beta 0
Volatility % 55.13
14-Day RSI 59.85
14-Day ATR ($) 0.556644
20-Day SMA ($) 8.296
12-1 Month Momentum % -49.14
52-Week Range ($) 6.3 - 17.53
Shares Outstanding (Mil) 61.66

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bioventus Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More